We at Gongwin Biopharm Co., Ltd are researching and developing an innovative ‘Minimally Invasive Targeted Tumor Ablation’ technique for treating focal malignancies. Our proprietary core technology is intra-tumoral injection of PTS (Para Toluene Sulfonamide) by combining the active therapeutic agent and following minimally invasive intervention techniques, which is unique and distinct from traditional anti-tumor therapies that are being opted by medical professionals. Core benefits for patients: Targeted selectivity – Onset within 24hours of injection & almost no damage to adjacent tissue. Broader Efficacy – Application in head & neck, breast, lung, liver & other cancer types. Safety – No severe systemic toxicities.
View Top Employees from Gongwinbiopharm 共信醫藥PTS| Website | https://tw.gongwinbiopharm.com/ |
| Revenue | $10 million |
| Employees | 20 (14 on RocketReach) |
| Founded | 2014 |
| Address | Sec. 1 Jianguo N. Rd Zhongshan Dist. Taipei No 80 10491, TW |
| Phone | 0225035282 |
| Industry | Biotechnology Research, Manufacturing General, Pharmaceuticals, Manufacturing |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Gongwinbiopharm 共信醫藥PTS employee's phone or email?
Gongwinbiopharm 共信醫藥PTS Questions
The Gongwinbiopharm 共信醫藥PTS annual revenue was $10 million in 2024.
Ben Liu is the Director of Gongwinbiopharm 共信醫藥PTS.
14 people are employed at Gongwinbiopharm 共信醫藥PTS.
The NAICS codes for Gongwinbiopharm 共信醫藥PTS are [3254, 32541, 32, 325].
The SIC codes for Gongwinbiopharm 共信醫藥PTS are [28, 283].
Top Gongwinbiopharm 共信醫藥PTS Employees
-
1
-
2
-
ViewChi-Chiang Tu
Director, Medical Research Division at Gongwinbiopharm 共信醫藥PTS
Taipei City, Taiwan, Taiwan21
